耐药性癫痫患者的在体9.4特斯拉MRI:技术报告
一例36岁男性耐药性局灶性癫痫患者,3T与7T MRI均未检出致痫灶,采用9.4T T1与T2*加权癫痫专用扫描方案。9.4T较3T和7T提供更高空间分辨率和关键解剖结构显示,但内侧颞叶与前下颞叶成像存在挑战,仍未发现致痫灶。9.4T在显示解剖结构和细小致痫灶方面有前景,其相对7T的临床优势及能否改善切除范围与 seizure 结局尚待确立。
要点
- 36岁男性耐药性局灶性癫痫患者,3T和7T MRI均未检出致痫灶。
- 9.4T MRI较3T和7T显示更高空间分辨率和关键癫痫相关解剖结构。
- 内侧颞叶和前下颞叶成像在9.4T存在挑战,该例仍未检出致痫灶。
核心结论
- 9.4T在识别和描绘耐药性癫痫患者解剖结构及细小致痫灶方面显示出前景。
- 9.4T相对于7T是否具有临床优势、能否带来更完整的致痫区切除和更好的癫痫手术结局尚待确立。
研究设计与样本
- 技术报告:一例36岁男性耐药性局灶性癫痫患者,评估切除手术前3T和7T MRI均未检出致痫灶,接受9.4T T1与T2*加权癫痫专用扫描方案。
- 图像由两名神经放射科医生和一名神经外科医生独立评估。
主要发现
- 9.4T MRI较3T和7T提供更高空间分辨率和关键癫痫成像解剖结构的增强显示,例证包括内侧颞叶(海马、杏仁核)、外侧颞叶、岛叶、额叶和颞叶盖部及灰白质交界(中央前回/额叶)。
- 9.4T在内侧颞叶和前下颞叶成像存在挑战。
- 9.4T未发现致痫灶。
局限性
- 9.4T在内侧颞叶和前下颞叶成像存在挑战。
- 9.4T相对于7T是否具有临床优势、能否带来更完整的致痫区切除和更好的癫痫手术结局尚待确立。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: In resective epilepsy surgery for drug-resistant focal epilepsy (DRE), good seizure outcome is strongly associated with visualization of an epileptogenic lesion on MRI. Standard clinical MRI (≤ 3 Tesla (T)) may fail to detect subtle lesions. 7T MRI enhances detection and delineation, the potential benefits of increasing field strength to 9.4T are explored. METHODS: A 36 years old male patient with DRE evaluated for resective surgery, in which 3T and 7T MRI failed to detect any epileptogenic lesions, was submitted to a dedicated epilepsy scan protocol using T1 and T2* weighted imaging at 9.4T. Images were evaluated independently by two neuroradiologists and one neurosurgeon. RESULTS: 9.4T MRI offered increased spatial resolution and enhanced depiction of anatomical structures vital for epilepsy imaging, exemplified by regions mesio-temporal (hippocampus, amygdala), latero-temporal, insula, frontal and temporal operculum, and gray-white matter junction (precentral gyrus/frontal lobe) compared to 3T and 7T, albeit with challenges in mesial-temporal and antero-inferior temporal lobe imaging. No epileptogenic lesion was identified. CONCLUSION: 9.4T demonstrates promise in the identification and delineation of anatomical structures and small epileptogenic lesions in patients with DRE eligible for resective surgery. Whether clinical 9.4T MRI in DRE has clinical advantages over 7T or leads to a more complete resection of the epileptogenic zone and improved seizure outcome after epilepsy surgery needs to be established.
引用
- van Lanen RHGJ, Uher D, Tse DHY, et al. In vivo 9.4 Tesla MRI of a patient with drug-resistant epilepsy: Technical report. Acta Neurochir (Wien). 2025. PMID: 39820684. doi:10.1007/s00701-024-06385-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。